Pantoprazole 40 MG Injection

Pantoprazole 40 mg Injection
Rapid IV Relief for Acid-Related Disorders

Pantoprazole 40 mg Injection is a fast-acting proton pump inhibitor (PPI) indicated for the management of acid-related gastrointestinal conditions, especially when oral therapy is not feasible. Administered intravenously, it provides effective suppression of gastric acid secretion, making it ideal for use in critical care, surgical, and emergency settings.

Key Benefits:

• Rapid and Potent Acid Suppression
  Effectively blocks the H⁺/K⁺ ATPase enzyme system, reducing gastric acid at the source.

• IV Administration for Acute Cases
  Suitable for NPO (nil per os) patients, post-operative care, and ICU settings where oral treatment isn’t possible.

• Proven Efficacy in GI Protection
  Prevents stress ulcers, treats GERD complications, and supports healing of peptic ulcers.

• Well-Tolerated Profile
  Minimal side effects and low risk of drug interactions; suitable for a wide range of patients.

Indications:

• GERD with erosive esophagitis

• Zollinger-Ellison syndrome

• Peptic ulcer disease

• Stress ulcer prophylaxis in critically ill patients

• Upper GI bleeding (adjunctive therapy)

Dosage & Administration:
Typically administered as an intravenous injection of 40 mg once daily or as directed by a physician, based on clinical condition.

Important Safety Information:
Use with caution in patients with hepatic impairment. Prolonged use may be associated with risks such as hypomagnesemia, vitamin B12 deficiency, and Clostridium difficile infection. Monitor electrolytes and kidney function as needed.